DELTA AND OMICRON COMBINATION NEW VARIANT: DELMICRON

Reading time is 1 mins

.
.
THE NIGHTMARE DOES NOT END! DELTA AND OMICRON COMBINATION NEW VARIANT DELMICRON

While the world was looking for ways to get rid of the coronavirus epidemic, another new variant appeared that bears the characteristics of both Delta and Omicron. Delmicron, which causes fear in the world and is referred to as a “double variant”, is thought to have the potential to cause extremely contagious and severe symptoms.

Delmicron, which is a combination of Delta and Omicron variants and is spreading rapidly, especially in the West, is spreading fear around the world. April to mid-June, the Delta variant dominated the world globally and has been cited as responsible for the second wave of coronavirus that claimed millions of lives.

The Omicron variant, which was first seen in South Africa and detected last month, showed much milder symptoms compared to the Delta variant, according to preliminary data. Researchers have shown by successive studies that, although highly contagious, it rarely causes serious symptoms and has a lower risk of hospitalization.

.
A DOUBLE VARIANT WITH A COMBINATION OF TWO VARIANTS

Doctor from India. “Delmicron came into existence following the rise of Delta and Omicron in Europe and the US,” told the Times of India. It is a double variant of Delmicron with combination of both Delta and Omicron’s spike proteins,” he said.

.
IT MAY SHOW SEVERE SYMPTOMS

On the other hand, Delmicron, on the other hand, is considered to have the potential to cause highly contagious and severe symptoms, since it was created by combining the Delta and Omicron versions of the coronavirus. However, further studies are needed to obtain detailed information about the nature of the double variant.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me